Last year I noticed that Quest Laboratories had changed
their method of calculating
low-density lipoprotein (LDL-C) on my lab report. For more than 40 years the
method used was the Friedewald
formula (LDL-C = TC – HDL – TG/5), where TG/5 (TG<400mg/dl) was a surrogate
for VLDL cholesterol. The method Quest uses now is the Martin/Hopkins method.
Quest says that this “novel” method is “more accurate than the usual method.”
Of course, the most accurate method to
measure LDL-C is a DIRECT measurement, not a calculation. Dr. Michael Eades
explains this on his website and I discuss it here. It requires another test – a special test
which is expensive and generally not done unless you request it and your doctor and insurer agree.
I’m writing about this change because, based on what Dr.
Eades wrote, and from my own affirming
data, I assumed that Quest changed to the new method because the new method
reported a lower LDL-C. To my surprise, while doing some research
recently, I discovered that the new method actually shows a higher LDL-C.
I found the story here in MEDPAGE TODAY, under Cardiology >
Dyslipidemia. The sub-title of the article is, “Friedewald lowballed lipids; Martin/Hopkins was on par with lab
reference” [for patients with stable CVD].
“According to an analysis of the FOURIER trial, the median Martin/Hopkins LDL cholesterol level
was 2mg/dl below the reference standard of preparative ultracentrifugation – a
statistically similar result, whereas the
Friedewald method underestimated LDL cholesterol by 4mg/dl (P<0.001)” (all emphases added by me).
So, relative to Friedewald, Martin/Hopkins
produced an LDL-C that was 2mg/dl
higher.
“While 22.9% of Martin/Hopkins
LDL cholesterol values were at least 5mg/dl different from reference and 2.6%
were off by more than 10mg/dl, these proportions were 40.1% and 13.3% with Friedewald estimation.” NB: “The
difference between methods was more pronounced when triglyceride levels
exceeded 150mg/dl.”
While the MEDPAGE TODAY article did not give the whole Martin/Hopkins formula, it did reveal
that “the Martin/Hopkins method
‘uses the same standard lipid measurements of total and HDL (high-density
lipoprotein) cholesterol and triglycerides as the Friedewald equation does, but it uses a personalized rather than a
fixed conversion factor in calculating LDL cholesterol levels,’ Martin and
colleagues noted.”
A “personalized conversion factor”? If Quest’s use of a personal
conversion factor usually results in an LDL-C higher (even if only 2
mg/dl), I find it intriguing that on the three lab reports I’ve had since Quest
switched to the Martin/Hopkins
method, my personal LDL-C values have all dropped below where they were
before. This is why I presumed, based
on what Dr. Eades had said about a DIRECT measurement, that my own values would
probably be lower, not higher, using the new method as it was
intended.
For the 3 tests before the switch from Friedewald to Martin/Hopkins,
my LDL-C values were 101, 114 and 100mg/dl. Then, using Martin/Hopkins, the Quest reports for my last 3 labs were 87, 79
and 83mg/dl. Of course, my labs were for different samples, but I have not
changed my Way of Eating. Why are my LDLs lower?
Cholesterol
|
198
|
201
|
196
|
184
|
173
|
189
|
HDL
|
85
|
74
|
74
|
83
|
81
|
92
|
Chol/HDL ratio
|
2.3
|
2.7
|
2.6
|
2.2
|
2.1
|
2.1
|
LDL (calc.)
|
101
|
114
|
100
|
87*
|
79*
|
83*
|
non-HDL
|
113
|
127
|
122
|
101
|
92
|
97
|
Triglycerides (TG)
|
60
|
67
|
108**
|
56
|
53
|
56
|
* calculated by Martin/Hopkins method ** first TG > 100mg/dl in 12 years
The JAMA article explains: Martin/Hopkins uses statistics for 3 stratifications of TGs from
100 to 399mg/dl, which resulted in higher LDLs. My lower
LDLs are because my 3 most recent TGs have all been in
the mid-50s.
No comments:
Post a Comment